{
    "clinical_study": {
        "@rank": "85726", 
        "arm_group": [
            {
                "arm_group_label": "Colistimethate sodium inhalation", 
                "description": "Colistimethate sodium inhalation for patients with ventilator-associated tracheobronchitis, pneumonia or lower respiratory tract colonization by multidrug resistant Gram-negative bacteria.\nAdditional intravenous colistimethate sodium for patients with ventilator-associated pneumonia"
            }, 
            {
                "arm_group_label": "saline inhalation", 
                "description": "saline inhalation for patients with ventilator-associated tracheobronchitis, pneumonia or lower respiratory tract colonization by multidrug resistant Gram-negative bacteria."
            }
        ], 
        "brief_summary": {
            "textblock": "There might be additional benefit on clinical outcomes from adjunctive colistimethate sodium\n      inhalation as therapy for multidrug resistant Gram-negative ventilator-associated pneumonia."
        }, 
        "brief_title": "Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Ventilator Associated Pneumonia", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Pneumonia", 
                "Pneumonia, Ventilator-Associated"
            ]
        }, 
        "detailed_description": {
            "textblock": "Besides, early antibiotics intervention might be benefit for patients with\n      ventilator-associated tracheobronchitis or lower airway colonization with multidrug\n      resistant Gram-negative bacteria."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. age \u2265 20 years old\n\n          2. medical ICU patients with invasive ventilator use \u2265 48 hours\n\n          3. multidrug resistant Gram-negative bacteria obtained from lower respiratory tract\n\n        Exclusion Criteria:\n\n          1. pregnancy\n\n          2. concurrent use of other antimicrobial agents active for isolated multidrug resistant\n             Gram-negative bacteria (as defined as resistant to carbapenem, fluoroquinolone, and\n             anti-pseudomonas beta-lactams), such as tigecycline, aminoglycosides, and sulbactam\n\n          3. patients who refuse to receive any inhaled therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients in medical intensive care unit with ventilator use"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01975350", 
            "org_study_id": "201303119MINB"
        }, 
        "intervention_browse": {
            "mesh_term": "Colistin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Colistimethate sodium inhalation", 
        "lastchanged_date": "October 28, 2013", 
        "location": {
            "contact": {
                "email": "whsheng@ntu.edu.tw; 007363@ntuh.gov.tw", 
                "last_name": "Wang-Huei Sheng, M.D. Ph.D", 
                "phone": "886-2-23123456", 
                "phone_ext": "67736"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan"
                }, 
                "name": "National Taiwan University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Ying-Chun Chien, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Yu-Chung Chuang, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "2", 
        "official_title": "Prospective Observation of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Tracheobronchitis/Pneumonia or Lower Respiratory Tract Colonization by Multidrug Resistant Gram-negative Bacteria", 
        "overall_contact": {
            "email": "whsheng@ntu.edu.tw; 007363@ntuh.gov.tw", 
            "last_name": "Wang-Huei Sheng, M.D. Ph.D", 
            "phone": "886-2-23123456", 
            "phone_ext": "67736"
        }, 
        "overall_contact_backup": {
            "email": "019466@ntuh.gov.tw", 
            "last_name": "Ying-Chun Chien, M.D.", 
            "phone": "886-2-23123456", 
            "phone_ext": "67736"
        }, 
        "overall_official": {
            "affiliation": "Center of Infection Control of National University Hospital", 
            "last_name": "Wang-Huei Sheng, M.D. Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "including clinical improvement and microbiological outcome(eradication of the pathogen as no growth of the pathogen in the final culture of specimens during the entire hospitalization)", 
            "measure": "clinical cure rate", 
            "safety_issue": "No", 
            "time_frame": "From date of starting colistimethate sodium to 28th days or til discharge from hospital, whichever came first, assessed up to 28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01975350"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "intensive care unit stay", 
                "safety_issue": "No", 
                "time_frame": "From date of starting colistimethate sodium to discharge date of intensive care unit, assessed up to 3 months"
            }, 
            {
                "measure": "hospital stay", 
                "safety_issue": "No", 
                "time_frame": "From date of starting colistimethate sodium to discharge date of hospital, assessed up to 3 months"
            }, 
            {
                "measure": "all cause mortality", 
                "safety_issue": "No", 
                "time_frame": "From date of starting colistimethate sodium to 28th days or til death, whichever came first, assessed up to 28 days"
            }, 
            {
                "measure": "ventilator-associated pneumonia-related mortality", 
                "safety_issue": "No", 
                "time_frame": "Death that occurred during the colistimethate sodium treatment period when the signs of pneumonia remained and as death due to septic shock, assessed up to 28 days"
            }, 
            {
                "measure": "microbiologic eradication in colonization patients", 
                "safety_issue": "No", 
                "time_frame": "From date of starting colistimethate sodium to 28th days or til discharge from hospital, whichever came first, assessed up to 28 days"
            }, 
            {
                "measure": "ventilator-associated pneumonia rate", 
                "safety_issue": "No", 
                "time_frame": "From date of starting colistimethate sodium to discharge date of hospital, assessed up to 3 months"
            }
        ], 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}